SMSPHARMA

** Shares of SMS Pharmaceuticals SMSP.NS jump 7.4% to 248.48 rupees; set for best day since late-April

** The U.S. FDA concluded inspection at its Hyderabad facility in Telangana state with no observations

** Stock on track for busiest trading session in two months, volumes at 7.7x the 30-day avg

** Year-to-date, stock up 4%

(Reporting by Manvi Pant in Bengaluru)

(([email protected]; +918447554364;))

Alerts on FalconPoint Partners acquiring U.S.-based industrial services business SMS were incorrectly tagged to SMS Pharmaceuticals SMSP.NS, an unrelated company, and have been withdrawn.

For the correct alert, click here.

STORY_NUMBER:nTUA6NX5T2

STORY_DATE:26/08/2025

STORY_TIME:01:00 PM GMT

(([email protected]))

June 27 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• SMS PHARMACEUTICALS LTD - INCREASES HOLDING IN SMS PEPTIDES TO 99.98%

• SMS PHARMACEUTICALS LTD - COST OF ACQUISITION 30 MILLION RUPEES

Source text: ID:nBSE32TlBn

Further company coverage: SMSP.NS

(([email protected];))

** Shares of SMS Pharmaceuticals SMSP.NS jumps 5.2% to 252 rupees, on track for third straight session of gains

** Co says U.S. FDA concluded an inspection at its Gagillapur facility in Telangana state with no observations

** More than 300,000 shares traded, 3.1x its 30-day moving avg

** YTD, stock up 0.10%

(Reporting by Yagnoseni Das in Bengaluru)

(([email protected];))

June 25 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• COMPLETES USFDA INSPECTION AT CENTRAL LABORATORY ANALYTICAL SERVICES

• USFDA INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS

Source text: ID:nNSEbttpLK

Further company coverage: SMSP.NS

(([email protected];;))

Oct 1 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• RECEIVES EDQM CERTIFICATION TO SUPPLY IBUPROFEN IN EUROPE

Source text for Eikon: ID:nNSE14Q7HP

Further company coverage: SMSP.NS

(([email protected];;))

Aug 5 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• SMS PHARMACEUTICALS JUNE-QUARTER CONSOL NET PAT 163.7 MILLION RUPEES

• SMS PHARMACEUTICALS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.64 BILLION RUPEES

Source text for Eikon: [ID:]

Further company coverage: SMSP.NS

(([email protected];))

Feb 8 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• DEC-QUARTER CONSOL NET PROFIT 122.9 MILLION RUPEES VERSUS 52.8 MILLION RUPEES

• DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.61 BILLION RUPEES VERSUS 1.49 BILLION RUPEES

• APPROVED RAISING OF FUNDS THROUGH ISSUE OF CONVERTIBLE EQUITY WARRANTS UP TO 1.14 BILLION RUPEES

Source text for Eikon: ID:nBSE77lJkx

Further company coverage: SMSP.NS

(([email protected];))

** Shares of SMS Pharmaceuticals SMSP.NS up as much as 7.9% to 130.65 rupees, touching their highest level since Sept. 4

** Stock posts biggest intraday pct gain since Aug. 24; on track for a fifth consecutive sessions of gains, if trends hold

** The pharmaceutical manufacturing co reported a more than 16-fold surge in profit to 120.5 mln rupees ($1.45 million) from 7.3 mln rupees a year earlier

** Revenue from operations rose 4.5% to 1.67 bln rupees

** More than 683,000 shares change hands by 1:33 p.m. IST, 12.8x its 30-day avg

** Stock currently up 3.4%, bumping YTD gains to 51.03%

($1 = 83.2700 Indian rupees)

(Reporting by Navamya Ganesh Acharya in Bengaluru)

(([email protected]; +91 8805175330 ;))

May 24 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:

• INDIA'S SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL NET PAT 80.7 MILLION RUPEES VERSUS PROFIT 89 MILLION RUPEES

• SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.49 BILLION RUPEES VERSUS 609.2 MILLION RUPEES

Source text for Eikon: ID:nBSEbTmNmR

Further company coverage: SMSP.NS

(([email protected];))